The patient is the driving force that spurs our collective goal to deliver optimal cancer care. As primary beneficiaries of oncology innovation, patients should play a leading role from research and development to the delivery of care. This summer, leaders from across the oncology community will convene in the nation’s capital to explore the role of the patient across the continuum of cancer research and care, and delineate strategies for policymakers to consider that support meaningful patient engagement and deliver value to patients.
Join conference co-hosts, the Personalized Medicine Coalition, the American Association for Cancer Research, Feinstein Kean Healthcare, and CancerCare, for the Turning the Tide Against Cancer Through Sustained Medical Innovation 2017 National Conference on June 29, 2017, at the Ronald Reagan Building and International Trade Center in Washington, D.C. Space is limited, register today.
Engage with representatives from the clinical, scientific, patient, and policy communities to identify policy pathways related to:
- Where does oncology innovation stand and where is it headed under a new Administration?
- What is the patient’s role in innovation as the key beneficiary of value-based care?
- What tools can we leverage to incentivize patient-driven value in oncology care?
The conference agenda is now available! To view the lineup of confirmed speakers and discussion topics, click here.